Endocannabinoidome and its role in neurological disorders-A comprehensive update of existing literature
Open Access
- 3 June 2021
- journal article
- Published by Heighten Science Publications Corporation in Journal of Neuroscience and Neurological Disorders
- Vol. 5 (1), 034-047
- https://doi.org/10.29328/journal.jnnd.1001049
Abstract
Medical benefits of cannabis and related compounds is widely known. Discovery of psychotropic plant cannabinoid Δ9-tetrahydrocannabinol have urged researchers to study more about the cannabinoid system and related therapeutics in the field of neurology and medicine. Where activation of cannabinoid receptor type 1 (CB1R) yielded in unwanted and serious side effects, discovery of cannabinoid receptor type 2 (CB2R) and its ligands gave a new hope. Till now there is limited success in this field because of complex expanded endocannabinoid system comprising of receptors, ligands and enzymes. In this review we will update about the role of endocannabinoidome relevant to neurological disorders.Keywords
This publication has 100 references indexed in Scilit:
- Cannabinoid- and lysophosphatidylinositol-sensitive receptor GPR55 boosts neurotransmitter release at central synapsesProceedings of the National Academy of Sciences of the United States of America, 2013
- CB2 Cannabinoid Receptors Promote Neural Progenitor Cell Proliferation via mTORC1 SignalingOnline Journal of Public Health Informatics, 2012
- Monoacylglycerol Lipase Exerts Dual Control over Endocannabinoid and Fatty Acid Pathways to Support Prostate CancerCell Chemical Biology, 2011
- CB2 receptor activation attenuates microcirculatory dysfunction during cerebral ischemic/reperfusion injuryMicrovascular Research, 2009
- Identification of the sites of 2-arachidonoylglycerol synthesis and action imply retrograde endocannabinoid signaling at both GABAergic and glutamatergic synapses in the ventral tegmental areaNeuropharmacology, 2008
- Biology and therapeutic potential of cannabinoid CB2 receptor inverse agonistsBritish Journal of Pharmacology, 2008
- The cannabinoid receptor agonist nabilone for the treatment of dementia‐related agitationInternational Journal of Geriatric Psychiatry, 2007
- Δ9-tetrahydrocannabinol (Δ9-THC) prevents cerebral infarction via hypothalamic-independent hypothermiaLife Sciences, 2007
- Cannabidiol inhibits human glioma cell migration through a cannabinoid receptor‐independent mechanismBritish Journal of Pharmacology, 2005
- Anandamide content is increased and CB1 cannabinoid receptor blockade is protective during transient, focal cerebral ischemiaNeuroscience, 2004